SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599901-23-000093
Filing Date
2023-11-08
Accepted
2023-11-08 16:14:00
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rna-20230930.htm   iXBRL 10-Q 846999
2 EX-31.1 rna-20230930xexx311.htm EX-31.1 9615
3 EX-31.2 rna-20230930xex312.htm EX-31.2 9634
4 EX-32.1 rna-20230930xex321.htm EX-32.1 4860
5 EX-32.2 rna-20230930xex322.htm EX-32.2 4852
  Complete submission text file 0001599901-23-000093.txt   4794894

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20230930.xsd EX-101.SCH 28610
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rna-20230930_cal.xml EX-101.CAL 52010
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rna-20230930_def.xml EX-101.DEF 146178
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20230930_lab.xml EX-101.LAB 517399
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20230930_pre.xml EX-101.PRE 314893
52 EXTRACTED XBRL INSTANCE DOCUMENT rna-20230930_htm.xml XML 610042
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 231388011
SIC: 2834 Pharmaceutical Preparations